Aquestive Therapeutics (AQST)
(Real Time Quote from BATS)
$3.07 USD
-0.13 (-4.06%)
Updated Jul 22, 2024 11:14 AM ET
5-Strong Sell of 5 5
F Value F Growth C Momentum F VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
AQST 3.07 -0.13(-4.06%)
Will AQST be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for AQST based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for AQST
New Strong Sell Stocks for July 16th
New Strong Sell Stocks for July 11th
AQST: What are Zacks experts saying now?
Zacks Private Portfolio Services
5 Small Drug Stocks to Buy From a Recovering Industry
Compared to Estimates, Aquestive Therapeutics (AQST) Q1 Earnings: A Look at Key Metrics
Aquestive Therapeutics (AQST) Reports Q1 Loss, Misses Revenue Estimates
Other News for AQST
Optimistic Outlook for Aquestive Therapeutics’ Anaphylm with Positive PK Results and Strategic FDA Engagement
Aquestive Therapeutics to Participate in Leerink Partners Therapeutics Forum: I&I and Metabolism
Oral Allergy Medication For Emergencies - Aquestive Therapeutics' Investigational Therapy Works Even With Exposure To Liquids Of Different Temperatures, Data Shows
Aquestive gains after initial data for allergy candidate
Aquestive Therapeutics Reports Positive Topline Data from Temperature / pH Study of Anaphylm™ (epinephrine) Sublingual Film